Pharmacokinetics of single dose intravenous infusion of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment / 上海第二医科大学学报
Article
in Zh
| WPRIM
| ID: wpr-640830
Responsible library:
WPRO
ABSTRACT
0.05). Conclusion The elimination half-life of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment is 27 h,and the regiment of 100 mg once a day is recommended.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Journal of Shanghai Jiaotong University(Medical Science)
Year:
2006
Document type:
Article